Bank Of America Corp Atreca, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.13 - $0.38 $74 - $218	575 New	575 $0
Q1 2023 May 12, 2023	SELL	$0.91 - $1.82 $32 - $65	-36 Reduced 0.24%	15,133 $17,000
Q4 2022 Feb 10, 2023	SELL	$0.78 - $1.68 $2,003 - $4,315	-2,569 Reduced 14.48%	15,169 $12,000
Q3 2022 Nov 14, 2022	SELL	$1.59 - $2.74 $19,423 - $33,471	-12,216 Reduced 40.78%	17,738 $28,000
Q2 2022 Aug 12, 2022	SELL	$1.56 - $3.25 $105,232 - $219,235	-67,457 Reduced 69.25%	29,954 $53,000
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $55,594 - $179,561	-34,531 Reduced 26.17%	97,411 $309,000
Q4 2021 Feb 08, 2022	BUY	$2.87 - $6.29 $285,309 - $625,295	99,411 Added 305.59%	131,942 $399,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $74,317 - $137,283	-15,136 Reduced 31.75%	32,531 $203,000
Q2 2021 Sep 13, 2021	BUY	$7.82 - $13.8 $372,755 - $657,804	47,667 New	47,667 $407,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.